Association of Helicobacter pylori infection with elevated serum lipids

Atherosclerosis

Volumn 142, Issue 1, 1999, Pages 207-210

  Laurila, Aino ^a   Bloigu, Aini ^a   Näyhä, Simo ^b   Hassi, Juhani ^b   Leinonen, Maija ^a   Saikku, Pekka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Antibodies; Atherosclerosis; Chronic infections

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CORONARY RISK; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL, HDL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 0032890181     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00194-4     Document Type: Article

References (25)

1. Megraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol. Clin. North. Am. 22:1993;73-88.
2. Saikku P., Leinonen M., Mattila K. et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-985.
3. Thom D.H., Grayston J.T., Siscivick D.S., Wang S.P., Weiss N.S., Daling J.R. Association of prior infection with Chlamydia pneumoniae and angiographically-demonstrated coronary heart disease. J. Am. Med. Assoc. 268:1992;68-72.
4. Mendall M.A., Goggin P., Molineaux N. et al. Relation of Helicobacter pylori infection and coronary heart disease. Br. Heart. J. 71:1994;437-439.
5. Glynn J. Helicobacter pylori and the heart. Lancet. 344:1994;146.
6. Gallin J.I., Kaye D., O'Leary W.M. Serum lipids in infection. New. Engl. J. Med. 281:1969;1081-1086.
7. Alvarez C., Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin. Chem. 32:1986;142-145.
8. Kerttula Y., Weber T. Serum lipids in pneumonia of different aetiology. Ann. Clin. Res. 20:1988;184-188.
9. Rubin L. Serum lipoproteins in infectious mononucleosis. Am. J. Med. 17:1954;521-527.
10. Stoesser A.V. Study of cholesterol fractions in acute infections. Proc. Soc. Exp. Biol. Med. 32:1935;1324-1327.
11. Laurila A., Bloigu A., Näyhä S., Hassi J., Leinonen M., Saikku P. Chlamydia pneumoniae antibodies and serum lipids in Finnish men. Br. Med. J. 314:1997;1456-1457.
12. Näyhä S, Hassi J, editors. Lifestyle, work and health of Finnish reindeer herders. Helsinki, Finland: Social Insurance Institution, 1993 (Publication ML 127).
13. Murray L.J., Bamford K.B., O'Reilly D.P.J., McGrum E.E., Evans A.E. Helicobacter pylori infection, relation with cardiovascular risk factors, ischemic heart disease, and social class. Br. Heart. J. 74:1994;497-501.
14. Patel P., Mendall M.A., Carrington D. et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br. Med. J. 311:1995;711-714.
15. Niemelä S., Karttunen T., Korhonen T., Läärä E., Karttunen R., Ikäheimo M., Kesäniemi Y.A. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart. 75:1995;573-575.
16. Wald N.J., Law M.R., Morris J.K., Bagnall A.M. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. Br. Med. J. 315:1997;1199-1201.
17. Grunfeld C., Gulli R., Moser A.H., Gavin L.A., Feingold K.R. Effect of tumour necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J. Lipid. Res. 30:1989;579-585.
18. Pocock S.J., Shaper A.G., Phillips A.N. Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. Br. Med. J. 298:1989;998-1002.
19. Frick M.H., Manninen V., Huttunen J.K., Heinonen O.P., Tenkanen L., Mänttäri M. HDL-cholesterol as a risk factor in coronary heart disease. An update of the Helsinki Heart Study. Drugs. 40:1990;7-12.
20. Kaukoranta-Tolvanen S.S., Teppo A.M., Laitinen K., Saikku P., Linnavuori K., Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb. Pathog. 21:1996;215-221.
21. Lopes-Virella M.F. Interactions between bacterial lipopolysaccharide and serum lipoproteins and their possible role in coronary heart disease. Eur. Heart. J. 14:1993;118-124.
22. Mendall M., Carrington D., Strachan D. et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J. Infect. 30:1995;121-128.
23. Mattila K.J., Nieminen M.S., Valtonen V. et al. Association between dental health and acute myocardial infarction. Br. Med. J. 298:1989;779-781.
24. Campbell L.A., O'Brien E.R., Cappucio A.L. et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172:1995;585-588.
25. Juvonen J., Juvonen T., Laurila A. et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J. Vasc. Surg. 25:1997;499-505.